Related Experiment Video
Updated: Jun 28, 2026

Prehospital Thrombolysis: A Manual from Berlin
Published on: November 26, 2013
Pre-hospital thrombolysis in perspective
Nicolas Danchin1, Eric Durand, Didier Blanchard
1Hôpital Européen Georges Pompidou, Assistance Publique des Hôpitaux de Paris and Université Paris 5 René Descartes, Paris, France. nicolas.danchin@egp.aphp.fr
Insights
Pre-hospital fibrinolysis significantly reduces mortality in ST-elevation myocardial infarction (MI) patients. Optimizing treatment timing and considering patient factors can further improve outcomes for this critical cardiac event.
Area of Science:
- Cardiology
- Emergency Medicine
- Pharmacology
Background:
- ST-elevation myocardial infarction (MI) has a high early mortality rate, with many deaths occurring within two hours of symptom onset.
- Despite advances, timely intervention remains crucial for improving survival rates in acute MI patients.
Purpose of the Study:
- To review existing evidence on the effectiveness of pre-hospital fibrinolysis in patients experiencing ST-elevation MI.
- To assess the role of timely interventions in reducing mortality associated with acute myocardial infarction.
Main Methods:
- Review of current treatment guidelines for ST-elevation MI.
- Analysis of data from clinical trials and patient registries.
- Evaluation of perfusion strategies and pre-hospital interventions.
Main Results:
- Pre-hospital fibrinolysis has demonstrated a reduction in overall one-month mortality for ST-elevation MI patients.
- Mortality rates can be further decreased by considering individual patient characteristics, risk factors, and treatment delays.
- Timely administration of reperfusion therapy is key to improving survival.
Conclusions:
- Time is a critical factor for successful fibrinolysis in ST-elevation MI.
- Subsequent coronary intervention following fibrinolysis appears to offer additional benefits in patient outcomes.
Aims:
To review existing evidence on the role of pre-hospital fibrinolysis in patients with ST-elevation myocardial infarction (MI).
Methods And Results:
Overview of current guidelines and data from trials and registries on the best perfusion approach for acute MI with ST-elevation. Despite advances in the treatment of ST-elevation MI, the mortality rate before any therapy is administered is high, with half of all fatalities occurring within 2 h of symptom onset. Current treatment options, including the timely use of pre-hospital fibrinolysis, have reduced the overall 1 month mortality. Mortality can be further improved when patient characteristics, risk factors and time delays to treatment are considered.
Conclusion:
Time factors are essential in the success of fibrinolysis, and subsequent coronary intervention seems beneficial.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Acute Coronary Syndrome IV: Interprofessional Care
Pulmonary Embolism III: Nursing Management
Clot Retraction and Fibrinolysis

